Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Recurrent Glioblastoma
Related studies linked through entity extraction aliases.
A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
- Status
- WITHDRAWN
- Phase
- PHASE1
RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
- Status
- RECRUITING
- Phase
- PHASE1
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
- Status
- SUSPENDED
- Phase
- PHASE2
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- Status
- RECRUITING
- Phase
- N/A
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- N/A
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
- Status
- RECRUITING
- Phase
- PHASE1
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
- Status
- RECRUITING
- Phase
- NA
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
- Status
- RECRUITING
- Phase
- PHASE2
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sonodynamic Therapy in Patients With Recurrent GBM
- Status
- RECRUITING
- Phase
- PHASE1
Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
TVI-Brain-1 in Expanded Access Patient
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A